HERON THERAPEUTICS, INC. /DE/ Convertible Notes Payable, Noncurrent
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Convertible Notes Payable, Noncurrent of $33.92 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2026-08-10
- 2026-06-30: Convertible Notes Payable, Noncurrent $33.92M.
- 2026-03-31: Convertible Notes Payable, Noncurrent $33.33M.
- 2025-12-31: Convertible Notes Payable, Noncurrent $32.74M.
- 2025-09-30: Convertible Notes Payable, Noncurrent $32.18M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2026-06-30 | $33.92M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $33.33M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $32.74M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $32.18M 10-Q · filed 2025-11-04 |
| 2025-03-31 | $149.75M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $149.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $149.65M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $149.59M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $149.54M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $149.49M 10-K · filed 2025-02-27 |
| 2023-09-30 | $149.44M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $149.39M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $149.34M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $149.28M 10-K · filed 2024-03-12 |
| 2022-09-30 | $149.23M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $149.18M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $149.13M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $149.08M 10-K · filed 2023-03-29 |
| 2021-09-30 | $149.03M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $148.98M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |